In the in vitro environment, CD45+/CD34+ primary bone marrow fibrocytes were stimulated by the ECM of IPF patients; then the hematopoietic surface antigens CD45 and CD34 rapidly disappeared, and mesenchymal markers, i.e., α-SMA, rapidly increased. The gene discussed is CD34; the disease is idiopathic pulmonary fibrosis.